RxSight, Inc. RXST
5.28 USD +0.38 (+7.76%)
At closeNov 11, 2026, 5:02 PM EST
5.25 -0.03 -0.57%
After hours · Nov 11, 5:02 PM ET
4.84 Day range 5.29
4.11 52-week range 13.22
- YTD
- -49.33%
- 1 year
- -48.39%
News
benzinga.com Piper Sandler Maintains Neutral on RxSight, Lowers Price Target to $8 Piper Sandler analyst Adam Maeder maintains RxSight (NASDAQ:RXST) with a Neutral and lowers the price target from $10 to $8.
benzinga.com Wells Fargo Maintains Equal-Weight on RxSight, Lowers Price Target to $6 Wells Fargo analyst Larry Biegelsen maintains RxSight (NASDAQ:RXST) with a Equal-Weight and lowers the price target from $9 to $6.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Curis (NASDAQ:CRIS) stock moved upwards by 83.5% to $1.31 during Wednesday's pre-market session. The company's market cap stands at $1.7 million. SCWorx (NASDAQ:WORX) stock increased by…
benzinga.com Needham Maintains Buy on RxSight, Lowers Price Target to $7 Needham analyst David Saxon maintains RxSight (NASDAQ:RXST) with a Buy and lowers the price target from $11 to $7.
seekingalpha.com RxSight, Inc. (RXST) Q3 2026 Earnings Call Transcript RxSight, Inc. (RXST) Q3 2026 Earnings Call Transcript
marketbeat.com What RxSight (RXST) Said on Its Q3 Earnings Call RxSight NASDAQ: RXST reported third-quarter revenue of $24.6 million, down 19% from $30.3 million a year earlier, as the company faced competitive pressure, seasonal effects and disruption tied to a…
zacks.com RxSight, Inc. (RXST) Reports Q3 Loss, Lags Revenue Estimates RxSight, Inc. (RXST) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to a loss of $0.04 per share a year ago.
benzinga.com RxSight Q3 2026 Earnings Call Transcript RxSight (NASDAQ:RXST) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
benzinga.com RxSight Q3 Adj. EPS $(0.21) Beats $(0.29) Estimate, Sales $24.586M Miss $27.137M Estimate RxSight (NASDAQ:RXST) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.29) by 27.59 percent. This is a 425 percent decrease over losses of $(0.04) per…
globenewswire.com RxSight, Inc. Reports Third Quarter 2026 Results ALISO VIEJO, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter ended September 30, 2026.
globenewswire.com RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules ALISO VIEJO, Calif., Oct. 23, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced that on October 23, 2026, RxSight granted inducement stock options to purchase a total of 236,456…
globenewswire.com RxSight, Inc. to Report Third Quarter 2026 Financial Results on November 3 ALISO VIEJO, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., today announced that it will report financial results for the third quarter of 2026 after the market close on…
globenewswire.com RxSight Appoints Eye Care Industry Leaders to Drive Commercial Transformation ALISO VIEJO, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced the appointments of Taryn Conway as Chief Commercial Officer and Frank Shields as Executive Vice…
globenewswire.com K2 Vision Has Been Recognized as the Highest-Volume Light Adjustable Lens practice in the world K2 Vision has performed 5,000+ Light Adjustable Lens procedures and is recognized by RxSight as the highest-volume LAL practice in the world. Learn more.
defenseworld.net Reviewing Bioventus (NASDAQ:BVS) & RxSight (NASDAQ:RXST) RxSight (NASDAQ: RXST - Get Free Report) and Bioventus (NASDAQ: BVS - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies…
defenseworld.net RxSight (NASDAQ:RXST) and Organigram Global (NASDAQ:OGI) Financial Survey RxSight (NASDAQ: RXST - Get Free Report) and Organigram Global (NASDAQ: OGI - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two…
defenseworld.net RxSight (NASDAQ:RXST) & Cerus (NASDAQ:CERS) Critical Analysis Cerus (NASDAQ: CERS - Get Free Report) and RxSight (NASDAQ: RXST - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based…- benzinga.com B of A Securities Maintains Underperform on RxSight, Lowers Price Target to $5.5 B of A Securities analyst Craig Bijou maintains RxSight (NASDAQ:RXST) with a Underperform and lowers the price target from $6.5 to $5.5.
defenseworld.net 85,838 Shares in RxSight, Inc. $RXST Purchased by Corient Private Wealth LP Corient Private Wealth LP bought a new stake in shares of RxSight, Inc. (NASDAQ: RXST) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor…
defenseworld.net BlackRock Inc. Purchases Shares of 5,790,408 RxSight, Inc. $RXST BlackRock Inc. acquired a new stake in RxSight, Inc. (NASDAQ: RXST) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The…
globenewswire.com RxSight, Inc. to Participate in the Wells Fargo Healthcare Conference ALISO VIEJO, Calif., Aug. 26, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced that management is scheduled to participate in the Wells Fargo Healthcare Conference on Wednesday,…
benzinga.com Stifel Maintains Hold on RxSight, Lowers Price Target to $7 Stifel analyst Tom Stephan maintains RxSight (NASDAQ:RXST) with a Hold and lowers the price target from $8 to $7.
defenseworld.net Head-To-Head Comparison: RxSight (NASDAQ:RXST) and Futureworld (OTCMKTS:FWDG) RxSight (NASDAQ: RXST - Get Free Report) and Futureworld (OTCMKTS:FWDG - Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two businesses…- benzinga.com UBS Maintains Neutral on RxSight, Raises Price Target to $6.3 UBS analyst Patrick Wood maintains RxSight (NASDAQ:RXST) with a Neutral and raises the price target from $5.5 to $6.3.
seekingalpha.com RxSight, Inc. (RXST) Q2 2026 Earnings Call Transcript RxSight, Inc. (RXST) Q2 2026 Earnings Call Transcript
marketbeat.com RxSight Q2 Earnings Call Highlights RxSight NASDAQ: RXST reported second-quarter revenue of $33.7 million, including $6.5 million recognized under its strategic collaboration with Alcon, while management withdrew its full-year 2026…- defenseworld.net RxSight Q2 Earnings Call Highlights RxSight (NASDAQ: RXST) reported second-quarter revenue of $33.7 million, including $6.5 million recognized under its strategic collaboration with Alcon, while management withdrew its full-year 2026…
zacks.com RxSight, Inc. (RXST) Reports Q2 Loss, Beats Revenue Estimates RxSight, Inc. (RXST) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to a loss of $0.08 per share a year ago.
globenewswire.com RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook ALISO VIEJO, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter ended June 30, 2026, and provided an update on its 2026 financial…- benzinga.com RxSight Appoints Aziz Mottiwala President, CEO, Effective July 20, Succeeding Ron Kurtz RxSight, Inc. (NASDAQ:RXST) today announced a planned leadership transition effective July 20, 2026, with Aziz Mottiwala appointed President and Chief Executive Officer, succeeding Ron Kurtz, M.D.,…
benzinga.com B of A Securities Maintains Underperform on RxSight, Lowers Price Target to $6.5 B of A Securities analyst Craig Bijou maintains RxSight (NASDAQ:RXST) with a Underperform and lowers the price target from $8 to $6.5.
benzinga.com Stock Market Today: Dow Jones Futures Gain, S&P 500, Nasdaq 100 Slips As SpaceX Debuts On The Exchange—Rivian, Micron In Focus (UPDATED) U.S. stock futures were mixed on Tuesday, as the Dow Jones index rose while the Nasdaq 100 and S&P 500 indices fell.
benzinga.com Rivian Automotive, Penguin Solutions And 3 Stocks To Watch Heading Into Tuesday US stock futures trade lower, investors focus on PENG, RXST, SAR earnings, RIVN's public offering, and EPAC's expected earnings. Check premarket coverage.
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Vicore Pharma Holding (NASDAQ:VCRE) stock rose 149.8% to $42.47 during Monday's after-market session. Crinetics Pharmaceuticals (NASDAQ:CRNX) stock moved upwards by 99.85% to $84.0. The…- benzinga.com RxSight Raises FY2026 Sales Guidance from $120.000M-$135.000M to $140.000M-$160.000M vs $129.250M Est RxSight (NASDAQ:RXST) raises FY2026 sales outlook from $120.000 million-$135.000 million to $140.000 million-$160.000 million vs $129.250 million estimate.
benzinga.com RxSight Sees Q2 Revenue Of $32M-$34M; Sees FY2026 Revenue Of $140M-$160M RxSight, Inc. (NASDAQ:RXST) today announced select preliminary financial results for the second quarter of 2026 and updates to its standalone product pipeline, following the announcement of the…- benzinga.com Alcon And RxSight Announce A Non-Exclusive Collaboration To Jointly Develop Adjustable Presbyopia-Correcting Intraocular Lenses Alcon (NYSE:ALC), the global leader in eye care dedicated to helping people see brilliantly, and RxSight, Inc. (NASDAQ:RXST), an ophthalmic medical device company dedicated to providing high-quality…
benzinga.com Wells Fargo Maintains Equal-Weight on RxSight, Lowers Price Target to $9 Wells Fargo analyst Larry Biegelsen maintains RxSight (NASDAQ:RXST) with a Equal-Weight and lowers the price target from $11 to $9.
benzinga.com Needham Maintains Buy on RxSight, Lowers Price Target to $11 Needham analyst David Saxon maintains RxSight (NASDAQ:RXST) with a Buy and lowers the price target from $13 to $11.
benzinga.com Earnings Scheduled For May 6, 2026 - benzinga.com RxSight Affirms FY2026 Sales Guidance of $120.000M-$135.000M vs $129.182M Est 2026 Guidance: The company's 2026 financial guidance is as follows:Revenue of $120 to $135 million, in-line with previous guidanceGross margin of 70% to 72%, in-line with previous guidanceOperating…
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga.com Earnings Scheduled For February 25, 2026
benzinga.com Planet Labs PBC, Day One Biopharmaceuticals, Rxsight, SunOpta And Other Big Stocks Moving Higher On Monday 
benzinga.com Ross Stores Posts Strong Q3 Results, Joins Enviri, Azenta And Other Big Stocks Moving Higher On Friday - benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com Earnings Scheduled For November 5, 2025 
benzinga.com Earnings Scheduled For August 7, 2025 - benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com Dow Jumps 200 Points; US Wholesale Inventories Fall 0.3% In May